Adult Glioblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Knockdown of GRP78 in glioblastoma cell lines induces CHOP and activates caspase-7 in temozolomide-treated cells.
|
17942911 |
2007 |
Childhood Glioblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Knockdown of GRP78 in glioblastoma cell lines induces CHOP and activates caspase-7 in temozolomide-treated cells.
|
17942911 |
2007 |
Glioblastoma Multiforme
|
0.020 |
Biomarker
|
disease |
BEFREE |
Knockdown of GRP78 in glioblastoma cell lines induces CHOP and activates caspase-7 in temozolomide-treated cells.
|
17942911 |
2007 |
Glioblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma.
|
18669646 |
2008 |
Adult Glioblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma.
|
18669646 |
2008 |
Childhood Glioblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma.
|
18669646 |
2008 |
Glioblastoma Multiforme
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Bcl2L12 (for Bcl2-Like12) is a nuclear and cytoplasmic oncoprotein that is universally overexpressed in primary GBM and functions to block postmitochondrial apoptosis signaling by neutralizing effector caspase-3 and caspase-7 maturation.
|
18669646 |
2008 |
Rheumatoid Arthritis
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
CASP7 rs2227309 SNP was not associated with RA in a European Caucasian population.
|
18785314 |
2008 |
Neoplasms
|
0.090 |
AlteredExpression
|
group |
BEFREE |
Reduction of Id2 expression also enhanced tumor cell apoptosis, increasing levels of the pro-apoptotic protein Bim/Bod, and cleavage of caspase-7 and poly (ADP-ribose) polymerase.
|
18806828 |
2008 |
Malignant Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Caspase7 (CASP7) is an executioner CASP that conducted a coordinated program of proteolysis that results in the destruction of critical cell structures, and it plays an important role in the development and progression of cancer.
|
19058873 |
2009 |
Primary malignant neoplasm
|
0.100 |
Biomarker
|
group |
BEFREE |
Caspase7 (CASP7) is an executioner CASP that conducted a coordinated program of proteolysis that results in the destruction of critical cell structures, and it plays an important role in the development and progression of cancer.
|
19058873 |
2009 |
Malignant neoplasm of lung
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
These results suggest that the CASP7 polymorphisms contribute to the genetic susceptibility to lung cancer.
|
19058873 |
2009 |
Carcinoma of lung
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
These results suggest that the CASP7 polymorphisms contribute to the genetic susceptibility to lung cancer.
|
19058873 |
2009 |
Primary malignant neoplasm of lung
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
These results suggest that the CASP7 polymorphisms contribute to the genetic susceptibility to lung cancer.
|
19058873 |
2009 |
Malignant Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Caspase-3, caspase-7, and caspase-8 are important caspases in the apoptosis pathway and play an important role in the development and progression of cancer.
|
19531679 |
2009 |
Primary malignant neoplasm
|
0.100 |
Biomarker
|
group |
BEFREE |
Caspase-3, caspase-7, and caspase-8 are important caspases in the apoptosis pathway and play an important role in the development and progression of cancer.
|
19531679 |
2009 |
Malignant neoplasm of endometrium
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Of 35 selected single-nucleotide polymorphisms, four in the caspase-7 gene were in high linkage disequilibrium (rs11593766, rs3124740, rs11196445, and rs11196418) and associated with the risk for endometrial cancer.
|
19531679 |
2009 |
Endometrial Carcinoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Of 35 selected single-nucleotide polymorphisms, four in the caspase-7 gene were in high linkage disequilibrium (rs11593766, rs3124740, rs11196445, and rs11196418) and associated with the risk for endometrial cancer.
|
19531679 |
2009 |
Non-Small Cell Lung Carcinoma
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
The CASP7 rs2227310 and CASP9 rs4645981 polymorphisms may affect survival in early-stage NSCLC.
|
19826114 |
2009 |
Spinocerebellar Ataxia Type 7
|
0.020 |
Biomarker
|
disease |
BEFREE |
The degradation of the caspase-7 cleavage product is mediated by macroautophagy in cell culture and primary neuron models of SCA7.
|
19955365 |
2009 |
Adenocarcinoma Of Esophagus
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
SNPs of rs3127075 in Caspase-7 (CASP7) and rs4661636 in Caspase-9 (CASP9) genes that play a critical role in apoptosis were found to be associated with an increased risk of EA.
|
20453000 |
2010 |
Colorectal Carcinoma
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
The RIPK1 and CASP7 polymorphisms can be considered as possible prognostic markers for survival after curative resection in patients with colorectal cancer.
|
20567846 |
2011 |
Malignant neoplasm of colon and/or rectum
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
The RIPK1 and CASP7 polymorphisms can be considered as possible prognostic markers for survival after curative resection in patients with colorectal cancer.
|
20567846 |
2011 |
Malignant neoplasm of lung
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
In individual polymorphism analysis, the CASP7 rs2227310C>G and CASP9 rs4645981C>T were associated with 1.40-fold and 1.28-fold increased risk of lung cancer under recessive and dominant models for the variant allele of each polymorphism, respectively.
|
20661084 |
2010 |
Carcinoma of lung
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
In individual polymorphism analysis, the CASP7 rs2227310C>G and CASP9 rs4645981C>T were associated with 1.40-fold and 1.28-fold increased risk of lung cancer under recessive and dominant models for the variant allele of each polymorphism, respectively.
|
20661084 |
2010 |